METHYLENE BLUE

Course overview

METHYLENE BLUE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF METHEMOGLOBINEMIA, A CONDITION IN WHICH HEMOGLOBIN DECREASES ITS ABILITY TO CARRY OXYGEN. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, ADVERSE EFFECTS, AND CONTRAINDICATIONS FOR METHYLENE BLUE AS A VALUABLE AGENT IN THE THERAPY OF METHEMOGLOBINEMIA, VASOPLEGIC SYNDROME, PLASMODIUM FALCIPARUM, AND ISOFOSFAMIDE-INDUCED ENCEPHALOPATHY, AS WELL AS FOR DIAGNOSTIC PURPOSES SUCH AS SENTINEL LYMPH NODE MAPPING DURING BREAST PROCEDURES AND PARATHYROID GLAND MAPPING DURING PARATHYROIDECTOMIES. THIS ACTIVITY WILL HIGHLIGHT THE INDICATIONS, MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS PERTINENT FOR MEMBERS OF A HEALTH-CARE TEAM MANAGING THE CARE OF PATIENTS WITH METHEMOGLOBINEMIA AND RELATED CONDITIONS.